Biophytis SA Sponsored ADR (BPTSY) vs Decoy Therapeutics Inc (DCOY)

Biophytis SA Sponsored ADR and Decoy Therapeutics Inc are both Biotechnology companies. Biophytis SA Sponsored ADR is the larger, with a market value of $2.4M against $2.0M — 1.2× the size. Biophytis SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. Biophytis SA Sponsored ADR has the higher net margin (0.00% vs −698.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Biophytis SA Sponsored ADR leads on 7 and Decoy Therapeutics Inc on 4.

Valuation

Metric BPTSY DCOY Biotechnology median
P/E n/m 0.02 7.88
P/S n/m 0.79 11.47
P/B n/m 0.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.42 0.74
EV/Sales n/m (2.99) 10.73
Earnings yield (126.92%) 5,960.59% (28.84%)
Free cash flow yield (2,235.65%) (637.25%) (23.03%)

Profitability

Metric BPTSY DCOY Biotechnology median
Gross margin 0.00% 10.57% 65.16%
Operating margin — (706.88%) 0.00%
Net margin 0.00% (698.79%) 0.00%
Free cash flow margin 0.00% (432.43%) 0.00%
Return on equity 0.00% (827.77%) (57.72%)
Return on assets 0.00% (278.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTSY DCOY Biotechnology median
Revenue growth (TTM) — (60.49%) 5.64%
EPS growth (last fiscal year) (59.60%) (85.66%) —
Revenue growth, 5-year CAGR — 12.73% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTSY DCOY Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 0.35 1.83 4.73
Net debt to EBITDA (1.24) 0.85 0.96

Dividend

Metric BPTSY DCOY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BPTSY DCOY Biotechnology median
Market cap 2.36m 1.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack